51 related articles for article (PubMed ID: 38469372)
1. FLAIR hyperintense cortical lesions in anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with seizure following SARS-CoV-2 mRNA vaccination.
Yoshino F; Ozaki Y; Shibahara T; Matsuoka M; Tachibana M; Ago T; Kitazono T; Kuroda J; Nakane H
eNeurologicalSci; 2024 Mar; 34():100492. PubMed ID: 38469372
[No Abstract] [Full Text] [Related]
2. A burning encephalitis: Fluid-attenuated inversion recovery-hyperintense lesions in Anti-myelin oligodendrocyte glycoprotein-associated encephalitis with seizures in anti-myelin oligodendrocyte glycoprotein-associated encephalitis with seizures-A case report and review of the literature.
El Ouali I; Naggar A; Berrada K; Jiddane M; Touarsa F
SAGE Open Med Case Rep; 2024; 12():2050313X241261021. PubMed ID: 38881971
[TBL] [Abstract][Full Text] [Related]
3. "FLAMES: A novel burning entity in MOG IgG associated disease".
Jain K; Cherian A; K P D; P R; Thomas B; J N
Mult Scler Relat Disord; 2021 Apr; 49():102759. PubMed ID: 33508569
[TBL] [Abstract][Full Text] [Related]
4. Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum.
Budhram A; Mirian A; Sharma M
Front Neurol; 2022; 13():1044642. PubMed ID: 36341089
[TBL] [Abstract][Full Text] [Related]
5. [Absence of cortical lesions after the first seizure in a patient with anti-myelin oligodendrocyte glycoprotein-associated cortical encephalitis].
Imai Y; Onoue H; Numahata K; Ogawa T; Akaiwa Y; Miyamoto T
Rinsho Shinkeigaku; 2023 Feb; 63(2):101-104. PubMed ID: 36725012
[TBL] [Abstract][Full Text] [Related]
6. Unilateral Autoimmune Encephalitis: A Case Report on a Rare Manifestation of Myelin Oligodendrocyte Glycoprotein Antibody Disease.
Maturu MVS; Datla AV; Maturu P; Talla VB; Dalai S
Cureus; 2023 Feb; 15(2):e34994. PubMed ID: 36938270
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
Matsumoto Y; Kaneko K; Takahashi T; Takai Y; Namatame C; Kuroda H; Misu T; Fujihara K; Aoki M
Brain; 2023 Sep; 146(9):3938-3948. PubMed ID: 37061817
[TBL] [Abstract][Full Text] [Related]
8. New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster.
Arismendez AA; Chopra J; Campbell T; Balsiger R; Vickers A
Can J Ophthalmol; 2023 Aug; 58(4):e181-e183. PubMed ID: 36803930
[No Abstract] [Full Text] [Related]
9. Relapsing Anti-MOG Antibody-associated Disease following COVID-19 Vaccination: A Rare Case Report and Review of the Literature.
Nakano H; Yamaguchi K; Hama N; Matsumoto Y; Shinohara M; Ide H
Intern Med; 2023 Mar; 62(6):923-928. PubMed ID: 36575011
[TBL] [Abstract][Full Text] [Related]
10. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
11. MOG-associated encephalitis following SARS-COV-2 infection.
Peters J; Alhasan S; Vogels CBF; Grubaugh ND; Farhadian S; Longbrake EE
Mult Scler Relat Disord; 2021 May; 50():102857. PubMed ID: 33647592
[TBL] [Abstract][Full Text] [Related]
12. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.
Rhea EM; Logsdon AF; Hansen KM; Williams LM; Reed MJ; Baumann KK; Holden SJ; Raber J; Banks WA; Erickson MA
Nat Neurosci; 2021 Mar; 24(3):368-378. PubMed ID: 33328624
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
